20261015_Cell Salvage Supplemental_RFI_Response Form_2.xlsx
XLSX spreadsheet 54 KB Posted
- Solicitation number
- FA800326SS004
About this file
This is a Request for Information (RFI) Response Form for a cell salvage device evaluation being conducted by the Department of the Air Force Materiel Command (AFMEDCOM) under solicitation number FA800326SS004. The RFI seeks market research to identify solutions capable of performing cell salvage, blood conditioning, and autonomous return with flow rate control to bridge the time to surgery in austere environments. The government is interested in both existing cleared devices and prototypes from large businesses and all categories of small businesses.
The response form outlines ten essential characteristics that potential vendors must address, including: FDA approval status or clear pathway to approval; use of FDA-cleared consumable items; real-time monitoring of device fluid pressure; ability to recover from any orientation within three minutes; cleared control and monitoring systems; user-selectable collection and return rates up to 1500 mL/min; gas exchange capability with selectable sweep gas flow rates up to 10 L/min; integrated hypothermia prevention through heating capability; and specific thermal performance (heating 450 cc of fluid from 2°C to 37°C). Vendors must indicate whether their device meets each requirement and provide detailed comments. The NAICS code 339112 (Surgical and Medical Instrument Manufacturing) may be used for this requirement. This is a pre-solicitation market research effort, and responses do not constitute binding offers or contracts.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| Cell Salvage Supplemental RFI.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Sheet1
| Cell Salvage Essential Characteristics | ||||
| # | Detailed Requirement Description | Comments | Meets (Y/N) | Vendor Comments |
| 1 | Planned FDA pathway | FDA approved or pending approval (with clear pathway and plan for final approval) | ||
| 2 | Comprised of FDA cleared consumable items | |||
| 3 | Realtime monitoring of device fluid pressure | Clinical monitor | ||
| 4 | Ability to recover from any orientation with in 3 min | Recover from upset or severe tilting during use | ||
| 5 | Cleared control/ monitoring system | |||
| 6 | Collection rate user selectable 0-1500mL/ min | device capability rate of fluid collection | ||
| 7 | Return rate user selectable 0-1500mL/ min | device capability rate of fluid return | ||
| 8 | Gas exchange 0-10L/ min sweep | device capability selectable sweep gas flow rate | ||
| 9 | Prevent hypothermia during treatment | Integrated heater prevents hypothermia from hemorrhage during use | ||
| 10 | Heat 450cc of fluid from 2oC to 37oC, <20 min | Standard atmosphere and pressure environment | ||
| 11 | Total system weight <40 pounds | |||
| 12 | Total system volume <8000 cubic inches | |||
| 13 | Storage requirements | No cold chain, sterile packaging lasts at least 1 year | ||
| 14 | Collection and return runtime of 2 hours @ 500ml/min (With Heating) | Runtime is based on battery power | ||
| 15 | Collection and return runtime of 4 hours @ 500ml/min (No Heating) | Runtime is based on battery power | ||
| 16 | Refit consumable items within 7 minutes single operator | Prepare blood contact items for next patient | ||
| 17 | Complete priming sequence within 15 minutes for a single operator | Simplified fluid priming system (dry to infusion) | ||
| 18 | Clear emboli <40 micron | Prepare blood for return or storage | ||
| 19 | Limits hemolysis to <1% PFhg during use | Measured per discreet blood volume | ||
| 20 | Automated emboli detection | User selectable alert to size of emboli detection | ||
| 21 | Can be used to prepare blood for later use | Fill blood bag | ||
| 22 | Single user operation | One person operation with limited training (medic) | ||
| 23 | Ability to treat hemorrhage without using donor (exogenous) blood products |
| Cell Salvage Preferences (Not Required) | ||
| 1 | Man-portable | Single person move, lift, carry |
| 2 | Ruggedized | MIL-STD-810G Standards to include acceleration, vibration, acoustic noise, shock, pyroshock, temperatue, and sand/dust. |
| 3 | Realtime monitoring of patient invasive BP | Clinical monitor/vitals monitor (Real-time monitoring of invasive BP would require an arterial line but not necessary. If possible, that is a plus for those situations where higher level providers are available.) |
| 4 | Realtime monitoring of oxygen saturation | Clinical monitor non invasive vitals monitor |
| 5 | Realtime monitoring of % Hematocrit | Clinical monitor non invasive blood monitor |
| 27 |
| 28 |
| 29 |
| 30 |
| 31 |
| 32 |
| 33 |
| 34 |
| 35 |
| 36 |
| 37 |
| 38 |
| 39 |
| 40 |
| 41 |
| 42 |
| 43 |
| 44 |
| 45 |
| 46 |
| 47 |
| 48 |
| 49 |
| 50 |
&"Times New Roman,Regular"&18Response Form #2
&G &"Arial,Regular"&10Page &P of &N image1.jpeg
File details come from the government source that posted it. Updated .